Col. Richard Kniseley, head of the Commercial Space Office (COMSO), speaks April 10 at the Space Symposium. Credit: Thomas Kimmell Photography COLORADO SPRINGS — An executive order issued April 9 by ...
New solution provides integrated provider intelligence and real-world data to optimize targeting, strategic planning and patient access across commercial organizations Tailored for the medtech sector, ...
Traditionally, leaders look to peers or more experienced professionals for guidance. However, reverse mentorship flips this dynamic, encouraging you to learn from those newer or closer to emerging ...
The medical technology sector, worth hundreds of billions of dollars, has experienced steady growth for years. And while it remains strong, recent headwinds are creating a more challenging environment ...
In the evolving landscape of financial services and data-driven strategy, the integration of artificial intelligence (AI) with pricing optimization is redefining how organizations achieve sustainable ...
Washington needs to do a better job of coordinating its private sector partnerships and investments in the Greater Central Asian region. Since the collapse of the Soviet Union, the United States has ...
Hospitality Sales and Marketing Association International Middle East and Africa (HSMAI MEA) lifts the lid on a power-packed programme for the 8th Annual HSMAI Commercial Strategy Conference MEA (CSC) ...
12 天on MSN
RxSight narrows 2025 revenue guidance to $125M–$130M while elevating gross margin outlook ...
Discover key Q3 2025 earnings insights for RxSight (RXST): revenue trends, rising gross margins, global growth, and strategic outlook.
The Fast Company Executive Board is a private, fee-based network of influential leaders, experts, executives, and entrepreneurs who share their insights with our audience. BY Fast Company Executive ...
Lifecore Biomedical has appointed Mark DaFonseca as its new chief commercial officer, bringing nearly 30 years of experience in drug development and over 15 years leading sales organizations in the ...
LONDON/COPENHAGEN, April 3 (Reuters) - Novo Nordisk's (NOVOb.CO), opens new tab head of commercial strategy and corporate affairs, Camilla Sylvest, has decided to leave the company, the Danish ...
CEO Catherine M. Szyman reported "our core Healthcare business delivered strong growth and earnings performance. Revenue was $370 million, and we achieved earnings per share of $1.33 with 600 basis ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果